Clik here to view.
糖尿病，利用胰脏细胞做根本性治疗的时代已经到来
首尔, 韩国 (美国商业资讯) — (株)STC LIFE(会长：李桂浩)干细胞治疗研究院(STC Stem cell Treatment & Research Institute / www.stcstri.com)通过数十年的研究成功利用能够分化为所有组织及脏器并无任何副作用的新万能细胞分化出担任胰脏中胰岛素调节机能的β细胞。 STC...
View ArticleClik here to view.
膵臓細胞利用により根本的治療の道が開かれる糖尿病 … STC Life、世界で初めて万能幹細胞から膵臓細胞への分化に成功
韓国・ソウル （ビジネスワイヤ） — STC Life Co., Ltd.（会長：KYE HO LEE）の幹細胞治療研究院（STC Stem cell Treatment & Research...
View ArticleClik here to view.
A New Era Comes When Diabetes Can Be Treated Basically Using Cells of Pancreas
SEOUL, South Korea STC Stem Cell Treatment & Research Institute (www.stcstri.com) of STC Life Co., Ltd. (Chairman: Kye Ho Lee) succeeded in differentiating new pluripotent stem cells without...
View ArticleClik here to view.
Ecolab Commits $1.5 Million to the Project WET Foundation to Support Water...
ST. PAUL, Minn. Ecolab Inc., the global leader in water, hygiene and energy technologies and services, has committed $1.5 million through the Ecolab Foundation to the Project WET Foundation, a...
View ArticleClik here to view.
Increasing Awareness of Bone Health Will Fast-track the Osteoporosis Drugs...
LONDON TechNavio has announced the publication of a new market research report on the Osteoporosis Drugs Market in APAC Region, which is expected to grow at a CAGR of 4.73 percent from 2015-2019....
View ArticleClik here to view.
Seattle Genetics和武田在ASH年会上报告ADCETRIS® (Brentuximab...
旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(TSE:4502)今天报告的数据显示，自体干细胞移植(ASCT)后有复发风险的霍奇金淋巴瘤(HL)患者，在ASCT后立即接受ADCETRIS (brentuximab...
View ArticleClik here to view.
武田呈报研究中的Ixazomib单药用于新诊断多发性骨髓瘤患者巩固治疗的2期数据
旧金山 (美国商业资讯) — 武田药品工业株式会社(TSE:4502)今天发布了一项2期开放研究的结果，该研究评估口服ixazomib...
View ArticleClik here to view.
Otsuka and Lundbeck Present Phase III Data on Brexpiprazole as Adjunctive...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the efficacy of...
View ArticleClik here to view.
Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce...
TOKYO & OSAKA, Japan & NEW YORK Ono Pharmaceutical Co.,Ltd. (Tokyo: 4528), Bristol-Myers Squibb Company (NYSE:BMY) and Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151,“Kyowa Hakko Kirin”) announced...
View ArticleClik here to view.
Seattle Genetics和武田在ASH年会上发布ADCETRIS® (Brentuximab...
旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社 (TSE:4502)今天发布了ADCETRIS (brentuximab vedotin)治疗复发或难治全身性间变性大细胞淋巴瘤(ALCL)枢纽性2期临床试验的4年总生存(OS)数据。ADCETRIS是一种靶向作用于CD30的抗体药物轭合物...
View ArticleClik here to view.
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the...
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris® (eculizumab) has been granted orphan drug designation (ODD) by Japan’s Ministry of Health, Labour and...
View ArticleClik here to view.
Otsuka and Lundbeck’s Brexpiprazole Demonstrates Statistically Significant...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the effects of an...
View ArticleClik here to view.
Nestlé Skin Health to Open Global Network of Innovation Hubs to Advance Next...
NEW YORK & LAUSANNE, Switzerland Nestlé Skin Health has announced plans to open a global network of ten innovation hubs around the world that will serve as a forum to develop solutions and...
View ArticleClik here to view.
Macrogen to Supply ‘X-Genome’ Genome Analysis Service to Institute of...
SEOUL, South Korea Customized medicine & biotechnology company Macrogen Inc. (CEO HyungTae Kim, www.macrogen.com) announced that it has made an agreement to supply the company’s X-Genome...
View ArticleClik here to view.
Wolters Kluwer Health Introduces UpToDate Anywhere Mobile Clinical Decision...
WALTHAM, Mass. Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today the Asian launch of UpToDate® Anywhere and its first...
View ArticleClik here to view.
Sosei Acquires Jitsubo, a Leading Japanese Peptide Technology Company
TOKYO Sosei Group Corporation (“The Group”)(TOKYO:4565) is pleased to announce that at the meeting of the Board of Directors held today, it resolved to acquire existing shares and underwrite a third...
View ArticleClik here to view.
FDA向MP Biomedicals签发有史以来首份HTLV证实性检测的核准书
加州圣安娜 (美国商业资讯)–生命科学试剂、精细化学品和诊断产品的领先提供商MP Biomedicals, LLC今天宣布，FDA已向该公司签发了MP Diagnostics HTLV（亲人类T淋巴细胞病毒）Blot 2.4检测的核准书，该检测采用Western 印迹法验证HTLV，并对病毒类型进行鉴别。这是美国有史以来首款获得FDA核准的HTLV证实性检测。 MP...
View ArticleClik here to view.
雀巢皮肤健康开启全球创新中心网络，以促进下一代皮肤健康
纽约市和瑞士洛桑 (美国商业资讯)–雀巢皮肤健康公司(Nestlé Skin Health)宣布，计划在世界各地开启10家创新中心的全球网络，作为开发解决方案和技术的论坛，该论坛进将通过医学研究、教育和皮肤健康技术的应用，来促进皮肤终身健康。该倡议回应了预期中的皮肤健康需求增长，因为在医疗保健和现代社会的背景中，皮肤健康对快速增长的老龄人群福祉的重要性已迫在眉睫。 Humberto C....
View ArticleClik here to view.
International Research on the Dorsal Root Ganglion (DRG) Presented at the...
LAS VEGAS At the 18th annual North American Neuromodulation Society (NANS) congress, researchers presented 20 international, peer-reviewed scientific abstracts from Australia and Europe highlighting...
View ArticleClik here to view.
Canada’s National Research Council Visits NCKU to Foster Collaboration
TAINAN, Taiwan A Canadian delegation led by Roman Szumski, the Vice President of Life Sciences at the National Research Council of Canada (NRC), visited National Cheng Kung University (NCKU),...
View Article